Sunday, February 15, 2026
  • English
  • Marathi
No Result
View All Result
Daily PRABHAT
  • Home
  • Latest News
  • National
  • International
  • Entertainment
  • Politics
  • Sports
  • Business
  • More
    • Health
    • Lifestyle
    • Technology
    • Science
Daily PRABHAT
No Result
View All Result
  • Home
  • Latest News
  • National
  • International
  • Entertainment
  • Politics
  • Sports
  • Business
  • More
Home National

COVID-19 vaccine Covovax now available for children in India: Adar Poonawalla

by
4 years ago
in National
A A
COVID-19 vaccine Covovax now available for children in India: Adar Poonawalla
Share on FacebookShare on Twitter

New Delhi [India], May 3 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said that the COVID-19 vaccine Covovax is now available in India for children.

He also hailed Prime Minister Narendra Modi for his vision of providing another vaccine for children.

Covovax (Novavax), is now available for children in India. This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of 90 per cent. This is in line with Prime Minister Narendra Modi’s vision of providing yet another vaccine to protect our children,” he said in a tweet.

Last week, the National Technical Advisory Group on Immunisation (NTAGI) approved the Serum Institute of India’s Covovax COVID-19 vaccine for the age group 12-17.

However, the Drugs Controller General of India’s (DCGI) subject expert committee has sought more data from the Pune-based Serum Institute of India (SII) on the Covovax vaccine for the age group of 7-12 years.

COVID-19 vaccination for minors in India started from January 3 onwards for those in the 15-18 age group with Bharat Biotech’s Covaxin. The drive later expanded on March 16 to include children aged above 12 for Biological E’s Corbevax. (ANI)

ShareTweetSendShareSend

Latest News

NDMC Vice Chairperson reviews AI Summit preparations to align with PM Modi’s vision

PM Modi hails Union Cabinet’s major decisions on railways, roads, infrastructure and connectivity

Gujarat gets 6th Vande Bharat Ahmedabad-Udaipur service, to be inaugrated on Feb 16

News must be presented with honesty, integrity in digital era: Tripura CM Saha at Bi-Annual State Conference

Himchal Governor, CM greet people on the eve of Shivratri

Cabinet approves rehabilitation, upgradation and widening of several National Highways

PM Modi targets Congress in poll-bound Assam; accuses it of appeasement politics, says it “never prioritized” nation’s security

Gujarat CM Bhupendra Patel releases ‘Mari Rashtraprathamni Kalpana’

Matter of immense pride that Northeast has got Emergency Landing Facility, says PM Modi; unveils projects worth over Rs 5,450 crore in Guwahati

Executive Engineer suspended after Mumbai metro pillar collapse

New Delhi [India], May 3 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said that the COVID-19 vaccine Covovax is now available in India for children.

He also hailed Prime Minister Narendra Modi for his vision of providing another vaccine for children.

Covovax (Novavax), is now available for children in India. This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of 90 per cent. This is in line with Prime Minister Narendra Modi's vision of providing yet another vaccine to protect our children," he said in a tweet.

Last week, the National Technical Advisory Group on Immunisation (NTAGI) approved the Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17.

However, the Drugs Controller General of India's (DCGI) subject expert committee has sought more data from the Pune-based Serum Institute of India (SII) on the Covovax vaccine for the age group of 7-12 years.

COVID-19 vaccination for minors in India started from January 3 onwards for those in the 15-18 age group with Bharat Biotech's Covaxin. The drive later expanded on March 16 to include children aged above 12 for Biological E's Corbevax. (ANI)

No Result
View All Result
  • Home
  • Latest News
  • National
  • International
  • Entertainment
  • Politics
  • Sports
  • Business
  • More
    • Health
    • Lifestyle
    • Technology
    • Science